Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05384873 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Immunonutrition for Improving the Efficacy of Immunotherapy in Patients With Metastatic Non-small Cell Lung Cancer

Study acronym: MURAL
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 1, 2025 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Jul 31, 2025 to Jul 31, 2026
    • Study completion date: Jul 31, 2026 to Jul 31, 2027
    v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jul 1, 2022 to Jun 1, 2023
    • Study sites: 0 to 1
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The present study was designed to evaluate the efficacy of the early systematic provision of oral nutritional supplements enriched in immunonutrients in non-small lung cancer patients undergoing immunotherapy and receiving nutritional counseling
Trial Details
NCT Number NCT05384873
Lead Sponsor Fondazione IRCCS Policlinico San Matteo di Pavia
Collaborators: San Luigi Gonzaga Hospital, Azienda Ospedaliera Universitaria Integrata Verona, Humanitas Hospital, Italy
Conditions
(from sponsor)		 Lung Cancer, Nonsmall Cell
Related terms Carcinoma, Non-Small-Cell Lung
Enrollment 180 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov